Leerink Partners Reiterates Market Perform on Cepheid (CPHD) Following 4Q

February 3, 2016 8:51 AM

Leerink Partners reiterated a Market Perform rating on Cepheid (NASDAQ: CPHD), and cut the price target to $33.00 (from $39.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found